Supercomputing Alliance opens access to sixteen sets of overcomputing resources to COVID-19 researchers

In response to the COVID-19 outbreak caused by the new coronavirus, the U.S. government, industry, and academia have made joint efforts to provide researchers with access to cloud computing resources from IBM’s world’s top supercomputers and enterprises such as Amazon/Microsoft/Google. The High Performance Computing Alliance says the supporting policy aims to look at how to control the spread of the disease and develop potential drugs.

Supercomputing Alliance opens access to sixteen sets of overcomputing resources to COVID-19 researchers

(Photo from: Carlos Jones / Oak Ridge National Laboratory, USA)

“By centralizing the computing power of supercomputers in a single consortium of partners, we can provide support to scientists, medical researchers, and government agencies to respond to and mitigate similar global emergencies,” said Dario Gil, IBM’s head of research.

A large group of machines, which can fill an entire floor of space, consume the same amount of electricity as a town. Previously, we knew that it was mostly used for missions such as nuclear explosion simulation, global climate impact research, and exploration of cosmophysics.

In addition, the rapid response of the alliance is clearly a welcome addition to the rapid spread of new coronaviruses and the resulting coVID-19 disease, given the rapid spread of the new coronavirus.

IBM is understood to have built some of the largest machines involved in the work, such as the Lassen supercomputer at The Lawrence Livermore National Laboratory (LLNL). It has 34,848 IBM Power9 processor cores and 3168 Nvidia graphics chips.

There are also a wide variety of machines involved, including access to resources from the three major cloud computing service providers (Amazon AWS, Microsoft Azure, Google Cloud).

But IBM’s Summit is still the world’s fastest supercomputer. It has been used in 8000 potentially effective coVID-19 compounds, as well as to prevent disease from infecting.

Finally, researchers at Oak Ridge National Laboratory and the University of Tennessee have tested 77 recommended drugs in experiments.